Centre médical Sheba
| Israël | Turquie | Espagne | |
| Thérapie CAR T | de $72,000 | de $150,000 | de $330,000 |
| Chimiothérapie pour le cancer du sein | de $22,500 | de $1,200 | de $3,500 |
| Chimiothérapie contre la leucémie | de $28,500 | de $8,000 | de $20,000 |
| Аphérèse thérapeutique | - | de $1,350 | - |
Spécialiste de premier plan des leucémies au centre médical Sourasky (Ichilov) – l'hôpital le plus grand et le plus avancé d'Israël.
Le Dr Ram a réalisé plusieurs centaines de greffes de cellules souches, un traitement fondamental de la leucémie, au centre médical Sourasky.
Chef de l'onco-hématologie pédiatrique à l'hôpital pour enfants Dana Dwek – Le Dr El Hasid se spécialise dans les greffes de moelle osseuse et de sang de cordon ombilical pour les enfants.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.